MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases

Breast Cancer Research

Volumn 13, Issue 5, 2011, Pages

  Pivetta, Eliana ^a   Scapolan, Martina ^a   Pecolo, Marina ^a   Wassermann, Bruna ^a   Abu Rumeileh, Imad ^a   Balestreri, Luca ^a   Borsatti, Eugenio ^a   Tripodo, Claudio ^b   Colombatti, Alfonso ^a,c   Spessotto, Paola ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; CYTOKINE; GALECTIN 3; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; MEMBRANE TYPE 1 METALLOPROTEASE; METALLOPROTEINASE; UNCLASSIFIED DRUG; PROTEIN PRECURSOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE EROSION; BONE MARROW; BONE MATRIX; BONE METASTASIS; BREAST TUMOR; CELL ACTIVATION; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN CLEAVAGE; TUMOR MICROENVIRONMENT; UPREGULATION; ADENOCARCINOMA; ANIMAL; BONE TUMOR; DRUG SCREENING; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; SECRETION (PROCESS); TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; BONE NEOPLASMS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLULAR MICROENVIRONMENT; CYTOKINES; EXTRACELLULAR MATRIX; FEMALE; GALECTIN 3; HUMANS; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; OSTEOCLASTS; PROTEIN PRECURSORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80054959382     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3047     Document Type: Article

References (33)

1. Coleman RE. Skeletal complications of malignancy. Cancer 1997, 80:1588-1594. 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G, 9362426.
2. Nakamura H, Sato G, Hirata A, Yamamoto T. Immunolocalization of matrix metalloproteinase-13 on bone surface under osteoclasts in rat tibia. Bone 2004, 34:48-56. 10.1016/j.bone.2003.09.001, 14751562.
3. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Otin C. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994, 269:16766-16773.
4. Balbin M, Pendas AM, Uria JA, Jimenez MG, Freije JP, Lopez-Otin C. Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors. APMIS 1999, 107:45-53. 10.1111/j.1699-0463.1999.tb01525.x, 10190279.
5. Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2002, 6:4823-4830.
6. Zhao W, Byrne MH, Boyce BF, Krane SM. Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J Clin Invest 1999, 103:517-524. 10.1172/JCI5481, 408105, 10021460.
7. Tchetina E, Mwale F, Poole AR. Distinct phases of coordinated early and late gene expression in growth plate chondrocytes in relationship to cell proliferation, matrix assembly, remodeling, and cell differentiation. J Bone Miner Res 2003, 18:844-851. 10.1359/jbmr.2003.18.5.844, 12733723.
8. Corte MD, Gonzalez LO, Corte MG, Quintela I, Pidal I, Bongera M, Vizoso F. Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma. Int J Biol Markers 2005, 20:242-248.
9. Leeman MF, McKay JA, Murray GI. Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol 2002, 55:758-762. 10.1136/jcp.55.10.758, 1769766, 12354802.
10. Balduyck M, Zerimech F, Gouyer V, Lemaire R, Hemon B, Grard G, Thiebaut C, Lemaire V, Dacquembronne E, Duhem T, Lebrun A, Dejonghe MJ, Huet G. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis 2000, 18:171-178. 10.1023/A:1006762425323, 11235993.
11. Luukkaa M, Vihinen P, Kronqvist P, Vahlberg T, Pyrhonen S, Kahari VM, Grenman R. Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head Neck 2006, 28:225-234. 10.1002/hed.20322, 16302191.
12. Culhaci N, Metin K, Copcu E, Dikicioglu E. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness. BMC Cancer 2004, 4:42. 10.1186/1471-2407-4-42, 512290, 15291964.
13. Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S, Li H, Ning L, Fu L, Niu Y, Niu R, Sun B, Hao X. Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer 2008, 8:83. 10.1186/1471-2407-8-83, 2362123, 18373849.
14. Nannuru KC, Futakuchi M, Varney ML, Vincent TM, Marcusson EG, Singh RK. Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface. Cancer Res 2010, 70:3494-3504. 10.1158/0008-5472.CAN-09-3251, 2862120, 20406980.
15. Pivetta E, Scapolan M, Wassermann B, Steffan A, Colombatti A, Spessotto P. Blood-derived human osteoclast resorption activity is impaired by hyaluronan-CD44 engagement via a p38-dependent mechanism. J Cell Physiol 2011, 226:769-779. 10.1002/jcp.22398, 20799279.
16. ImageJ software. , http://rsb.info.nih.gov
17. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996, 271:17124-17131. 10.1074/jbc.271.29.17124, 8663255.
18. Lu Y, Cai Z, Xiao G, Keller ET, Mizokami A, Yao Z, Roodman GD, Zhang J. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Res 2007, 67:3646-3653. 10.1158/0008-5472.CAN-06-1210, 17440076.
19. Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A. N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis. J Med Chem 2009, 52:4757-4773. 10.1021/jm900261f, 19606871.
20. Hernandez RM, Sorsa T, Obregon F, Tervahartiala T, Valenzuela MA, Pozo P, Dutzan N, Lesaffre E, Molas M, Gamonal J. Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade. J Clin Periodontol 2009, 36:1011-1017. 10.1111/j.1600-051X.2009.01488.x, 19929954.
21. Li YJ, Kukita A, Teramachi J, Nagata K, Wu Z, Akamine A, Kukita T. A possible suppressive role of galectin-3 in upregulated osteoclastogenesis accompanying adjuvant-induced arthritis in rats. Lab Invest 2009, 89:26-37. 10.1038/labinvest.2008.111, 19015643.
22. Guevremont M, Martel-Pelletier J, Boileau C, Liu FT, Richard M, Fernandes JC, Pelletier JP, Reboul P. Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3. Ann Rheum Dis 2004, 63:636-643. 10.1136/ard.2003.007229, 1755017, 15140769.
23. Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaisse JM. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000, 151:879-889. 10.1083/jcb.151.4.879, 2169432, 11076971.
24. Hou CH, Hsiao YC, Fong YC, Tang CH. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13. Bone 2009, 44:233-242. 10.1016/j.bone.2008.09.021, 19038372.
25. Yeh WL, Lu DY, Lee MJ, Fu WM. Leptin induces migration and invasion of glioma cells through MMP-13 production. Glia 2009, 57:454-464. 10.1002/glia.20773, 18814267.
26. Yu T, Wu Y, Helman JI, Wen Y, Wang C, Li L. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway. Mol Cancer Res 2011, 9:161-172. 10.1158/1541-7786.MCR-10-0386, 21205837.
27. Kinder M, Chislock E, Bussard KM, Shuman L, Mastro AM. Metastatic breast cancer induces an osteoblast inflammatory response. Exp Cell Res 2008, 314:173-183. 10.1016/j.yexcr.2007.09.021, 17976581.
28. Yammani RR, Long D, Loeser RF. Interleukin-7 stimulates secretion of S100A4 by activating the JAK/STAT signaling pathway in human articular chondrocytes. Arthritis Rheum 2009, 60:792-800. 10.1002/art.24295, 2676111, 19248116.
29. Ospelt C, Brentano F, Jungel A, Rengel Y, Kolling C, Michel BA, Gay RE, Gay S. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2009, 60:355-363. 10.1002/art.24226, 19180502.
30. Sakao K, Takahashi KA, Arai Y, Saito M, Honjo K, Hiraoka N, Asada H, Shin-Ya M, Imanishi J, Mazda O, Kubo T. Osteoblasts derived from osteophytes produce interleukin-6, interleukin-8, and matrix metalloproteinase-13 in osteoarthritis. J Bone Miner Metab 2009, 27:412-423. 10.1007/s00774-009-0058-6, 19333684.
31. Morgan H, Hill PA. Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity. Cancer Cell Int 2005, 5:1. 10.1186/1475-2867-5-1, 548674, 15701164.
32. Trebec DP, Chandra D, Gramoun A, Li K, Heersche JN, Manolson MF. Increased expression of activating factors in large osteoclasts could explain their excessive activity in osteolytic diseases. J Cell Biochem 2007, 101:205-220. 10.1002/jcb.21171, 17216600.
33. Guise TA. Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases. Genes Dev 2009, 23:2117-2123. 10.1101/gad.1854909, 2751987, 19759260.